RENE.L - ReNeuron Group plc

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Currency in GBp

Valuation measures4

Market cap (intra-day) 4.37M
Enterprise value -2.36M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.25
Price/book (mrq)0.86
Enterprise value/revenue -4.45
Enterprise value/EBITDA 0.37

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-77.50%
S&P500 52-week change 36.21%
52-week high 333.90
52-week low 30.00
50-day moving average 37.93
200-day moving average 315.36

Share statistics

Avg vol (3-month) 3223.21k
Avg vol (10-day) 3790.05k
Shares outstanding 557.17M
Implied shares outstanding 6N/A
Float 845.94M
% held by insiders 119.96%
% held by institutions 130.97%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 324 Jan 2018

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Mar 2023
Most-recent quarter (mrq)31 Mar 2023


Profit margin 0.00%
Operating margin (ttm)-1,342.45%

Management effectiveness

Return on assets (ttm)-32.98%
Return on equity (ttm)-72.37%

Income statement

Revenue (ttm)530k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-73.30%
Gross profit (ttm)N/A
Net income avi to common (ttm)-5.41M
Diluted EPS (ttm)-0.11
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.15M
Total cash per share (mrq)0.13
Total debt (mrq)421k
Total debt/equity (mrq)8.32
Current ratio (mrq)2.05
Book value per share (mrq)0.09

Cash flow statement

Operating cash flow (ttm)-7.48M
Levered free cash flow (ttm)-6.88M